An update on nesiritide for treatment of decompensated heart failure. - Wikidata - awgldk - TriplyDB

An update on nesiritide for treatment of decompensated heart failure.

An update on nesiritide for treatment of decompensated heart failure.

http://www.wikidata.org/entity/Q34232053

about

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics Emerging therapeutic targets in chronic heart failure: part I.Science or fiction: use of nesiritide as a first-line agent?Recent advances in natriuretic peptides in congestive heart failure.A review of the renal and neurohormonal effects of B-type natriuretic peptide.Determinants of natriuretic peptide production by the heart: basic and clinical implications.Natriuretic peptides: novel therapeutic targets in heart failure.Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy.Current and future uses of nesiritide.

P2860

Q27004000-F9662248-A7C6-4859-9D10-23843C65334F Q35020557-B83EEDB5-EEB0-46F7-A5EC-07F7CD6F3B1E Q35200887-3D1451F6-4EDF-4FB8-A62C-C50B7971291E Q35790792-E6E0F2E7-0884-4596-984D-63292FBCD525 Q36050051-4D6737B7-46B8-486B-BD5E-AE27AEBFEA85 Q36317209-4A98A3E4-57C6-4C62-A278-8D1D7E9497F8 Q36317213-1A9279C5-A70D-4B9B-A92A-BC22DFE88505 Q38534772-AA4CED38-139C-470F-8E8E-A6F2CBB29C5D Q40442907-71526D4A-8D86-45AB-9044-2EF18023A3E7

P2860

An update on nesiritide for treatment of decompensated heart failure.

http://www.wikidata.org/entity/Q34232053

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

An update on nesiritide for treatment of decompensated heart failure.

@ast

An update on nesiritide for treatment of decompensated heart failure.

@en

An update on nesiritide for treatment of decompensated heart failure.

@nl

type

label

An update on nesiritide for treatment of decompensated heart failure.

@ast

An update on nesiritide for treatment of decompensated heart failure.

@en

An update on nesiritide for treatment of decompensated heart failure.

@nl

prefLabel

An update on nesiritide for treatment of decompensated heart failure.

@ast

An update on nesiritide for treatment of decompensated heart failure.

@en

An update on nesiritide for treatment of decompensated heart failure.

@nl

P1433

Q34232053-A0884A46-EFE2-4B10-8CA5-F806745F74A5

P1476

Q34232053-052D1032-55B8-4114-81A8-88C2628034C1

P2093

Q34232053-29E1D567-3111-4EDA-9E15-1773F795DFBD

Q34232053-533D6FAE-AFAD-4830-9553-31F5D01270A9

Q34232053-85969024-C07C-4CA6-8354-4A25E7BA04FC

P2860

Q34232053-010418DA-5F11-4DB6-BB48-4C5EFA10540C

Q34232053-11235127-3212-42F3-AA3E-328AE41D8417

Q34232053-28D1E3FB-6544-425C-A4CB-FB0FFBEB68EA

Q34232053-35DF4037-FDE3-4720-AF6F-ADA8CEFCCF67

Q34232053-3616BF13-FA8F-47A0-BF18-35E19BE7CA8E

Q34232053-4684E79F-E94B-4D67-8B54-B7EF9CFB6265

Q34232053-6000325D-3A39-4965-A858-3C10504BF791

Q34232053-644D0366-CC3C-4706-B374-45A1D23615AF

Q34232053-6F268E60-0CFC-45D8-906D-5FC9FC04A8A4

Q34232053-7A672BAD-12DB-4F5D-99D8-3F5F3121A09F

P304

Q34232053-1F577648-3A4F-4574-AA11-DD22550FB21E

P31

Q34232053-DBC6ECEE-31F9-4DFD-8328-66DD4A292AE2

Q34232053-eb0d3a08-d5a0-4950-9023-486faa6885c1

P356

Q34232053-8F6AE05D-9949-4F61-BBD9-1AEF9FE401A7

P407

Q34232053-8468CEDD-AC3D-4435-9A69-26ADAD1D774E

P433

Q34232053-F563195F-EF5B-4626-9A73-911E6B7353A5

P478

Q34232053-B7FAA1D2-D141-40B5-9345-2A3FE67C3339

P577

Q34232053-F33918E2-39E4-458D-B9CD-105192C89B9E

P698

Q34232053-7DE598A6-CFA8-4552-ABFF-83F7F7951DC1

P356

13543784.10.5.935

P1433

Expert Opinion on Investigational Drugs

P1476

An update on nesiritide for treatment of decompensated heart failure.

@en

P2093

Hobbs RE

http://www.w3.org/2001/XMLSchema#string

Mills RM

http://www.w3.org/2001/XMLSchema#string

Young JB

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of the natriuretic peptides and their receptors

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Receptor guanylyl cyclases

Brain natriuretic peptide predicts mortality in the elderly.

Heart failure--implications of the true size of the problem.

Human brain natriuretic peptide reduces blood pressure in normotensive and acute norepinephrine-induced hypertensive rabbits.

Relaxant effect of human brain natriuretic peptide on human artery and vein tissue.

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

P304

935-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.10.5.935

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11322867

http://www.w3.org/2001/XMLSchema#string